|
Myelophthisic Anemia |
Replacement of BM, most often by malignancy |
|
What type of anemia is associated with phenytoin use? |
Megaloblastic |
|
Causes of aplastic anemia |
-most often d/t toxic exposure |
|
What are the general characteristics of hemolytic anemia? |
(increased red cell destruction) |
|
Warm antibody hemolytic anemia |
IgG Abs react with red cell surface antigens |
|
Paroxysmal Nocturnal hemoglobinuria |
-Increased sensitivity to complement-induced red cell lysis |
|
Hereditary spherocytosis |
AD |
|
G6PD deficiency |
X-linked; more often in AAs |
|
What are the myeloproliferative disorders? (4) |
CML |
|
Bernard-Soulier Disease |
AR |
|
Glanzmann thrombasthenia |
Inaggregability of platelets d/t hereditary deficiency of platelet-surface GPIIb/IIa, required for formation of fibrinogen bridges. |
|
Classic pentad of TTP |
fever |
|
When do you see macro-ovalocytes? What other blood cell abnormality is associated with it? |
Megaloblastic |
|
When do you see helmet cells or schistocytes? |
DIC, traumatic hemolysis |
|
When do you see "bite cells" |
G6PD deficiency |
|
When do you see "teardrop cells" |
Myeloid metaplasia with myelofibrosis |
|
When do you see target cells? |
HbC disease, Asplenia, Liver disease, Thalassemia |
|
When do you see poikilocytes? |
Nonuniform shapes in TTP/HUS, microvascular damage, DIC |
|
When do you see Burr cells? |
TTP/HUS, traumatic hemolysis |
|
When do you see basophilic stippling? |
Thalassemias, Anemia of chronic disease, Iron deficiency, lead poisoning (TAIL) |
|
What does dec. serum haptoglobin and inc. serum LDH indicate? |
RBC hemolysis |
|
What are the microcytic, hypochromic anemias? |
MCV < 80 |
|
What causes macrocytic anemia? |
Folate or B12 deficiency |
|
What causes normochromic, normocytic anemia? |
Acute hemorrhage |
|
Treatment of aplastic anemia |
-Withdrawal of offending agent, duh |
|
CLL markers |
CD5+, CD10- |
|
Hairy cell leukemia markers |
TRAP + |
|
CML markers |
t19;22 - philly chromosome |
|
MM markers |
IgG or IgA M protein spike |
|
Waldenstrom's markers |
IgM M protein spike |
|
Follicular lymphoma markers |
CD 19,20 +; CD5- |
|
Burkitt's markers |
EBV |
|
Small lymphocytic lymphoma markers |
CD5+, CD10- |
|
Mantle cell markers |
t(11;14) |
|
AML markers |
M3 type has t(15;17) |
|
ALL marker |
most common form is CD10+ |
|
What are the 2 primary opsonins in bacterial defense |
C3b and IgG |
|
What two factors help prevent complement activation on self-cells? |
DAF (decay-accelerating factor) and C1 esterase |
|
Deficiency of C1 esterase leads to: |
Hereditary angioedema |
|
Deficiency of C3 leads to: |
Severe, recurrent pyogenic sinus and URIs |
|
Deficiency of C6-C8 lead to: |
Neisseria bacteremia |
|
C1-4 used in? |
Viral neutralization |
|
C3a and C5a used for? |
Anaphylaxis |
|
C5a is specifically linked to? |
PMN chemotaxis |
|
C5b, C6-9 are associated with? |
Membrane attack complex |
|
What does deficiency of DAF lead to? |
complement-mediated lysis of RBCs and paroxysmal nocturnal hemoglobinuria. |





Review All